Evidence for a Difference in Nitric Oxide Biosynthesis Between Healthy Women and Men

There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of N nitrate excreted in urine after the intravenous administration of L-...

Full description

Saved in:
Bibliographic Details
Published inHypertension (Dallas, Tex. 1979) Vol. 32; no. 4; pp. 730 - 734
Main Authors Forte, Pablo, Kneale, Barry J., Milne, Eric, Chowienczyk, Phil J., Johnston, Atholl, Benjamin, Nigel, Ritter, James M.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Heart Association, Inc 01.10.1998
Hagerstown, MD Lippincott
Subjects
Online AccessGet full text

Cover

Loading…
Abstract There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of N nitrate excreted in urine after the intravenous administration of L-[() N] (2-guanidino) arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 [micro sign]mol L-[() N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary N/() N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary N nitrate excretion was greater in women than in men (2111 +/- 139 versus 1682 +/- 87 eta mol; P<0.05). Furthermore, total urinary N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women. (Hypertension. 1998;32:730-734.)
AbstractList Abstract —There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of 15 N nitrate excreted in urine after the intravenous administration of l -[ 15 N] 2 -guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 μmol l -[ 15 N] 2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary 15 N/ 14 N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary 15 N nitrate excretion was greater in women than in men (2111±139 versus 1682±87 ηmol; P <0.05). Furthermore, total urinary 15 N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P =0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women.
There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of 15N nitrate excreted in urine after the intravenous administration of L-[15N]2-guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 micromol L-[15N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary 15N/14N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary 15N nitrate excretion was greater in women than in men (2111+/-139 versus 1682+/-87 etamol; P<0.05). Furthermore, total urinary 15N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women.
There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of 15N nitrate excreted in urine after the intravenous administration of L-[15N]2-guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 micromol L-[15N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary 15N/14N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary 15N nitrate excretion was greater in women than in men (2111+/-139 versus 1682+/-87 etamol; P0.05). Furthermore, total urinary 15N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women.
There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of 15N nitrate excreted in urine after the intravenous administration of L-[15N]2-guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 micromol L-[15N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary 15N/14N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary 15N nitrate excretion was greater in women than in men (2111+/-139 versus 1682+/-87 etamol; P<0.05). Furthermore, total urinary 15N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women.There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of 15N nitrate excreted in urine after the intravenous administration of L-[15N]2-guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 micromol L-[15N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary 15N/14N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary 15N nitrate excretion was greater in women than in men (2111+/-139 versus 1682+/-87 etamol; P<0.05). Furthermore, total urinary 15N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women.
There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of N nitrate excreted in urine after the intravenous administration of L-[() N] (2-guanidino) arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 [micro sign]mol L-[() N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary N/() N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary N nitrate excretion was greater in women than in men (2111 +/- 139 versus 1682 +/- 87 eta mol; P<0.05). Furthermore, total urinary N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women. (Hypertension. 1998;32:730-734.)
Author Chowienczyk, Phil J.
Johnston, Atholl
Kneale, Barry J.
Milne, Eric
Benjamin, Nigel
Forte, Pablo
Ritter, James M.
AuthorAffiliation Received April 27, 1998; first decision May 12, 1998; revision accepted June 18, 1998. From the Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, London (P.F., A.J., N.B.); the Department of Clinical Pharmacology, UMDS, St Thomas' Hospital, London (B.J.K., P.J.C., J.M.R.); and the Rowett Research Institute, Aberdeen (E.M.), UK. Presented as an oral presentation at the 5th International Meeting on Biology of Nitric Oxide, Kyoto, Japan, September 15-19, 1997; published in abstract form (Jpn J Pharmacol. 1997;75:16P). Correspondence to Professor Nigel Benjamin, Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, Charterhouse Square, London, EC1 M 6BQ, UK. E-mail n.benjamin@mds.qmw.ac.uk
AuthorAffiliation_xml – name: Received April 27, 1998; first decision May 12, 1998; revision accepted June 18, 1998. From the Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, London (P.F., A.J., N.B.); the Department of Clinical Pharmacology, UMDS, St Thomas' Hospital, London (B.J.K., P.J.C., J.M.R.); and the Rowett Research Institute, Aberdeen (E.M.), UK. Presented as an oral presentation at the 5th International Meeting on Biology of Nitric Oxide, Kyoto, Japan, September 15-19, 1997; published in abstract form (Jpn J Pharmacol. 1997;75:16P). Correspondence to Professor Nigel Benjamin, Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, Charterhouse Square, London, EC1 M 6BQ, UK. E-mail n.benjamin@mds.qmw.ac.uk
Author_xml – sequence: 1
  givenname: Pablo
  surname: Forte
  fullname: Forte, Pablo
  organization: Received April 27, 1998; first decision May 12, 1998; revision accepted June 18, 1998. From the Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, London (P.F., A.J., N.B.); the Department of Clinical Pharmacology, UMDS, St Thomas' Hospital, London (B.J.K., P.J.C., J.M.R.); and the Rowett Research Institute, Aberdeen (E.M.), UK. Presented as an oral presentation at the 5th International Meeting on Biology of Nitric Oxide, Kyoto, Japan, September 15-19, 1997; published in abstract form (Jpn J Pharmacol. 1997;75:16P). Correspondence to Professor Nigel Benjamin, Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, Charterhouse Square, London, EC1 M 6BQ, UK. E-mail n.benjamin@mds.qmw.ac.uk
– sequence: 2
  givenname: Barry J.
  surname: Kneale
  fullname: Kneale, Barry J.
– sequence: 3
  givenname: Eric
  surname: Milne
  fullname: Milne, Eric
– sequence: 4
  givenname: Phil J.
  surname: Chowienczyk
  fullname: Chowienczyk, Phil J.
– sequence: 5
  givenname: Atholl
  surname: Johnston
  fullname: Johnston, Atholl
– sequence: 6
  givenname: Nigel
  surname: Benjamin
  fullname: Benjamin, Nigel
– sequence: 7
  givenname: James M.
  surname: Ritter
  fullname: Ritter, James M.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2421241$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9774371$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1vEzEQxS1UVNLCmRPSCqHeduvxx-76SEshSIVyKAJOluOMFZeNHewNaf57nCbqoQcsWdbz_N5oNO-EHIUYkJDXQBuAFs4pNIvtquGsEU3H6TMyAclELWTLj8iEghK1Avj5gpzkfEcpCCG6Y3Ksuk7wDibk9uqvn2OwWLmYKlN98M5hevjwofrqx-RtdXNfmOrCx7wN4wKzz9UFjhvEUE3RDONiW_2Iy6JMmFdfMLwkz50ZMr46vKfk-8er28tpfX3z6fPl--vaSkr7GqHnzPVKurazvXBCSGe5kaikoM7M0PRmJgCt4xS4tL2bsdZSMIqhEYbxU3K277tK8c8a86iXPlscBhMwrrNuleoolaqAb5-Ad3GdQplNMypZLyjjBXpzgNazJc71KvmlSVt92FWpvzvUTbZmcMkE6_MjxgQDJnbY-R6zKeac0D0SQPUuM01BT39905xpoUtmxSGfOKwfzehjGJPxw398Yu_bxGHElH8P6w0mvXiIRNNyBGv7GpTqYafqcsvK_wFP8qj1
CODEN HPRTDN
CitedBy_id crossref_primary_10_1152_ajpregu_00338_2003
crossref_primary_10_3390_jcm9123815
crossref_primary_10_1139_cjpp_2015_0272
crossref_primary_10_1002_cbdv_202400175
crossref_primary_10_1016_j_niox_2004_07_008
crossref_primary_10_1016_j_ijcard_2016_11_118
crossref_primary_10_1113_EP085148
crossref_primary_10_1016_j_schres_2018_12_015
crossref_primary_10_14814_phy2_13200
crossref_primary_10_1378_chest_14_0263
crossref_primary_10_1080_07420520600827129
crossref_primary_10_1371_journal_pone_0219481
crossref_primary_10_3109_00365513_2012_701322
crossref_primary_10_1152_ajpregu_00226_2013
crossref_primary_10_1016_j_bcp_2023_115737
crossref_primary_10_1183_16000617_0330_2020
crossref_primary_10_1590_S1517_86922006000400001
crossref_primary_10_1093_gerona_gls171
crossref_primary_10_1042_CS20040078
crossref_primary_10_1002_dmrr_3059
crossref_primary_10_1016_S0891_5849_03_00104_7
crossref_primary_10_1586_14779072_5_4_777
crossref_primary_10_1016_j_jpet_2025_103526
crossref_primary_10_1152_ajprenal_00228_2020
crossref_primary_10_1152_physiol_00001_2008
crossref_primary_10_1080_10408398_2011_651177
crossref_primary_10_1177_1091581809345924
crossref_primary_10_1152_ajpheart_00194_2018
crossref_primary_10_1152_ajpregu_00526_2009
crossref_primary_10_3390_nu11050954
crossref_primary_10_1111_apha_13637
crossref_primary_10_1086_683829
crossref_primary_10_1016_S1089_8603_02_00105_2
crossref_primary_10_2217_14796678_3_3_283
crossref_primary_10_1089_jwh_2010_2115
crossref_primary_10_1007_s11033_012_1492_4
crossref_primary_10_1152_ajpheart_00519_2017
crossref_primary_10_1016_j_niox_2021_11_001
crossref_primary_10_1002_nau_1006
crossref_primary_10_1016_j_atherosclerosis_2007_06_008
crossref_primary_10_1186_s12902_021_00817_3
crossref_primary_10_1371_journal_pone_0080101
crossref_primary_10_1016_j_semnephrol_2022_04_006
crossref_primary_10_1042_BSR20180111
crossref_primary_10_14814_phy2_15644
crossref_primary_10_1089_ars_2021_0212
crossref_primary_10_1016_j_cbpb_2004_02_022
crossref_primary_10_1172_JCI31093
crossref_primary_10_1371_journal_pone_0300844
crossref_primary_10_1186_s12931_023_02531_1
crossref_primary_10_1046_j_1444_2892_2000_009003113_x
crossref_primary_10_3109_00365521_2013_773459
crossref_primary_10_1152_japplphysiol_00099_2003
crossref_primary_10_1093_jn_134_10_2768S
crossref_primary_10_1038_sj_bjp_0706422
crossref_primary_10_1042_CS20240625
crossref_primary_10_1152_ajprenal_00009_2002
crossref_primary_10_1371_journal_pone_0009257
crossref_primary_10_1097_00075197_200301000_00015
crossref_primary_10_3945_jn_116_231910
crossref_primary_10_1007_s00431_013_1988_5
crossref_primary_10_14814_phy2_12125
crossref_primary_10_1016_j_lpm_2016_10_005
crossref_primary_10_1111_jch_12493
crossref_primary_10_1152_japplphysiol_00452_2007
crossref_primary_10_3390_ijerph10072813
crossref_primary_10_1111_apha_13937
crossref_primary_10_1093_gerona_gly087
crossref_primary_10_1016_j_jash_2007_02_002
crossref_primary_10_1269_jrr_07070
crossref_primary_10_1111_j_1475_097X_2009_00884_x
crossref_primary_10_1007_s11906_016_0689_7
crossref_primary_10_1021_jasms_1c00055
crossref_primary_10_1002_cbf_3741
crossref_primary_10_1590_S0102_86502002000600011
crossref_primary_10_1159_000355741
crossref_primary_10_3109_10739680903199186
crossref_primary_10_1016_j_niox_2014_03_162
crossref_primary_10_1111_j_1365_2362_2004_01339_x
crossref_primary_10_1002_ajh_23613
crossref_primary_10_1016_S0168_8227_02_00180_8
crossref_primary_10_1161_JAHA_114_001738
crossref_primary_10_1152_ajpheart_00142_2018
crossref_primary_10_3389_fphys_2019_00749
crossref_primary_10_1152_ajpheart_00823_2016
crossref_primary_10_1080_09537100701525843
crossref_primary_10_1097_HJH_0b013e32835731dd
crossref_primary_10_1016_j_semnephrol_2009_07_003
crossref_primary_10_1016_j_cjca_2014_03_020
crossref_primary_10_1016_j_lfs_2024_122432
crossref_primary_10_1016_j_mam_2011_02_001
crossref_primary_10_1038_sj_ki_5001680
crossref_primary_10_1016_j_atherosclerosis_2011_04_007
crossref_primary_10_1152_ajprenal_00482_2016
crossref_primary_10_1016_j_chest_2024_01_014
crossref_primary_10_1097_00004872_199917080_00001
crossref_primary_10_1002_jnr_23855
crossref_primary_10_1038_hr_2014_140
crossref_primary_10_1152_ajpendo_00527_2014
crossref_primary_10_6118_jmm_2018_24_2_75
crossref_primary_10_1097_00004872_200205000_00021
crossref_primary_10_1016_j_steroids_2013_01_003
crossref_primary_10_1152_ajpregu_00214_2007
crossref_primary_10_3389_fcvm_2023_1198090
crossref_primary_10_5402_2012_901801
crossref_primary_10_1007_s00380_018_1140_6
crossref_primary_10_1038_ajh_2009_155
crossref_primary_10_1186_s40168_020_00913_x
crossref_primary_10_1007_BF03345214
crossref_primary_10_1038_nrneph_2009_90
crossref_primary_10_1111_j_1440_1681_2007_04732_x
crossref_primary_10_4244_EIJ_D_19_00774
crossref_primary_10_1093_jn_nxaa318
crossref_primary_10_1007_s11906_002_0039_9
crossref_primary_10_1016_j_phrs_2011_08_009
crossref_primary_10_1038_jcbfm_2012_141
crossref_primary_10_1210_jcem_85_4_6530
crossref_primary_10_1007_s10545_008_0920_z
crossref_primary_10_17116_profmed201821248_54
crossref_primary_10_1093_ajcn_nqac277
crossref_primary_10_1016_j_freeradbiomed_2011_05_032
crossref_primary_10_1097_MD_0000000000034182
crossref_primary_10_1016_j_humimm_2008_03_003
crossref_primary_10_1152_ajprenal_00666_2013
crossref_primary_10_1203_01_pdr_0000214880_15623_84
crossref_primary_10_1186_s13102_021_00292_2
crossref_primary_10_1016_j_phrs_2016_10_018
crossref_primary_10_1093_ndt_gfl227
crossref_primary_10_1007_s43440_023_00499_9
crossref_primary_10_5812_scimetr_20987
crossref_primary_10_1093_nutrit_nuy005
crossref_primary_10_1016_j_vph_2009_05_002
crossref_primary_10_1042_CS20160047
crossref_primary_10_1186_1471_2369_11_20
crossref_primary_10_1016_j_hfc_2022_09_002
crossref_primary_10_1177_1753944707088904
crossref_primary_10_1067_mhl_2001_118764
crossref_primary_10_1016_j_vph_2017_09_003
crossref_primary_10_1177_2045894021989554
crossref_primary_10_1111_bph_14783
crossref_primary_10_23736_S0393_3660_19_04247_5
crossref_primary_10_1164_ajrccm_162_2_9909124
crossref_primary_10_1093_cvr_cvq309
crossref_primary_10_6118_jmm_2014_20_1_1
crossref_primary_10_1016_j_phrs_2017_01_023
crossref_primary_10_1366_000370206776023241
crossref_primary_10_1371_journal_pone_0090232
crossref_primary_10_1007_s40200_021_00799_y
crossref_primary_10_1139_apnm_2017_0696
crossref_primary_10_1146_annurev_pharmtox_010919_023229
crossref_primary_10_1016_j_genm_2008_03_006
Cites_doi 10.1021/bi00424a003
10.1161/res.73.6.8222083
10.1126/science.181.4105.1125
10.1006/bbrc.1994.2107
10.1016/0006-291X(85)90080-4
10.1136/hrt.72.3.243
10.1097/00004872-199209000-00017
10.1161/circ.81.6.2344673
10.1093/oso/9780192623683.003.0002
10.1111/j.1475-097X.1996.tb00726.x
10.1056/NEJM199312303292706
10.1016/0024-3205(95)02311-9
10.1016/S0140-6736(96)07631-3
10.1093/clinchem/35.6.1024
10.1152/ajpcell.1995.269.4.C884
10.2136/sssaj1989.03615995005300060016x
10.1177/000456329703400212
10.1016/S0140-6736(94)91285-8
10.1201/b14095
10.1016/S0140-6736(94)91342-0
10.1097/00005344-199204002-00061
10.1097/00010694-195811000-00011
ContentType Journal Article
Copyright 1998 American Heart Association, Inc.
1998 INIST-CNRS
Copyright American Heart Association, Inc. Oct 1998
Copyright_xml – notice: 1998 American Heart Association, Inc.
– notice: 1998 INIST-CNRS
– notice: Copyright American Heart Association, Inc. Oct 1998
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1161/01.hyp.32.4.730
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4563
EndPage 734
ExternalDocumentID 35166915
9774371
2421241
10_1161_01_HYP_32_4_730
00004268-199810000-00018
Genre Comparative Study
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
18M
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFFNX
AFNMH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BCGUY
BOYCO
BQLVK
BS7
C1A
C45
CS3
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB3
OCUKA
ODA
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YHZ
YOC
YYM
YYP
ZFV
ZGI
ZZMQN
AAYXX
ADGHP
CITATION
IQODW
OZ-
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OLW
RHF
K9.
7X8
ID FETCH-LOGICAL-c5008-e1832f895f67c84f445fc3a5e9540fabea8ab41ecf30135c8fb26c01a92ea4a23
ISSN 0194-911X
IngestDate Tue Aug 05 10:50:06 EDT 2025
Fri Jul 25 07:10:02 EDT 2025
Wed Feb 19 02:36:13 EST 2025
Mon Jul 21 09:15:55 EDT 2025
Thu Apr 24 23:08:15 EDT 2025
Tue Jul 01 01:44:28 EDT 2025
Fri May 16 03:51:27 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Human
Nitric oxide
Blood vessel
Sex
Female
Male
Biosynthesis
Circulatory system
Comparative study
Endothelium
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5008-e1832f895f67c84f445fc3a5e9540fabea8ab41ecf30135c8fb26c01a92ea4a23
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
PMID 9774371
PQID 205284023
PQPubID 47910
PageCount 5
ParticipantIDs proquest_miscellaneous_69970059
proquest_journals_205284023
pubmed_primary_9774371
pascalfrancis_primary_2421241
crossref_primary_10_1161_01_HYP_32_4_730
crossref_citationtrail_10_1161_01_HYP_32_4_730
wolterskluwer_health_00004268-199810000-00018
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1998-October
PublicationDateYYYYMMDD 1998-10-01
PublicationDate_xml – month: 10
  year: 1998
  text: 1998-October
PublicationDecade 1990
PublicationPlace Philadelphia, PA
Hagerstown, MD
PublicationPlace_xml – name: Philadelphia, PA
– name: Hagerstown, MD
– name: United States
– name: Baltimore
PublicationTitle Hypertension (Dallas, Tex. 1979)
PublicationTitleAlternate Hypertension
PublicationYear 1998
Publisher American Heart Association, Inc
Lippincott
Publisher_xml – name: American Heart Association, Inc
– name: Lippincott
References e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
(e_1_3_2_10_2) 1982; 126
e_1_3_2_19_2
e_1_3_2_1_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
(e_1_3_2_20_2) 1995; 26
References_xml – ident: e_1_3_2_16_2
  doi: 10.1021/bi00424a003
– ident: e_1_3_2_15_2
  doi: 10.1161/res.73.6.8222083
– ident: e_1_3_2_18_2
  doi: 10.1126/science.181.4105.1125
– ident: e_1_3_2_24_2
  doi: 10.1006/bbrc.1994.2107
– volume: 26
  start-page: E360
  year: 1995
  ident: e_1_3_2_20_2
  publication-title: Am J Physiol
– ident: e_1_3_2_8_2
  doi: 10.1016/0006-291X(85)90080-4
– ident: e_1_3_2_4_2
  doi: 10.1136/hrt.72.3.243
– ident: e_1_3_2_22_2
  doi: 10.1097/00004872-199209000-00017
– ident: e_1_3_2_23_2
  doi: 10.1161/circ.81.6.2344673
– ident: e_1_3_2_14_2
  doi: 10.1093/oso/9780192623683.003.0002
– ident: e_1_3_2_7_2
– ident: e_1_3_2_17_2
  doi: 10.1111/j.1475-097X.1996.tb00726.x
– ident: e_1_3_2_2_2
  doi: 10.1056/NEJM199312303292706
– ident: e_1_3_2_5_2
  doi: 10.1016/0024-3205(95)02311-9
– ident: e_1_3_2_9_2
  doi: 10.1016/S0140-6736(96)07631-3
– ident: e_1_3_2_21_2
  doi: 10.1093/clinchem/35.6.1024
– ident: e_1_3_2_19_2
  doi: 10.1152/ajpcell.1995.269.4.C884
– ident: e_1_3_2_11_2
  doi: 10.2136/sssaj1989.03615995005300060016x
– ident: e_1_3_2_25_2
  doi: 10.1177/000456329703400212
– ident: e_1_3_2_1_2
  doi: 10.1016/S0140-6736(94)91285-8
– ident: e_1_3_2_13_2
  doi: 10.1201/b14095
– ident: e_1_3_2_3_2
  doi: 10.1016/S0140-6736(94)91342-0
– ident: e_1_3_2_6_2
  doi: 10.1097/00005344-199204002-00061
– ident: e_1_3_2_12_2
  doi: 10.1097/00010694-195811000-00011
– volume: 126
  start-page: 131
  year: 1982
  ident: e_1_3_2_10_2
  publication-title: Anal Chem
SSID ssj0014447
Score 2.031583
Snippet There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO...
Abstract —There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to...
SourceID proquest
pubmed
pascalfrancis
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 730
SubjectTerms Adult
Arginine - administration & dosage
Arginine - metabolism
Biological and medical sciences
Blood Pressure
Blood vessels and receptors
Body Mass Index
Female
Fundamental and applied biological sciences. Psychology
Humans
Injections, Intravenous
Male
Muscle, Smooth, Vascular - metabolism
Nitrates - urine
Nitric Oxide - biosynthesis
Sex Characteristics
Vertebrates: cardiovascular system
Title Evidence for a Difference in Nitric Oxide Biosynthesis Between Healthy Women and Men
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004268-199810000-00018
https://www.ncbi.nlm.nih.gov/pubmed/9774371
https://www.proquest.com/docview/205284023
https://www.proquest.com/docview/69970059
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqISEkhLhNhDHwAw9IU0KcOLfHAUWFrgWkTnS8WI5raxOQVmsrVn49x5dcOhVxeUlb13ainM_H526EnpeJkoCdyI_KPPEpKBh-EYUzn8BmkHGSl5kxuI3G6eCUvp8m015v3c0uWZWB-Lkzr-R_qAptQFedJfsPlG0mhQb4DvSFK1AYrn9F4_pIUBsK2Rx2IkwhEFirOkp-fgV9jsqL-XJTgbCn64_UsVk2B3JjqzAYL8J3lxjmpNUBKKmXJsTdYCR_o63uNq5IXgVHpMiKjiUB9MlJfytlbDjuH5-YpldB638avTsZ97eTIAYfPmtb15ezoRlfd5416Xl1XJuzRjRVJbo2y4JqnjrtMt3WqNlaFAwHzZybRrpfdDefT4nJXQjON4sgjgIaNOO6FbWv7XRN_KHxg-tyBzci0C70wRfDT63ziVLqsuztc7uKUHDPl9fuuCXM3F7wJawrZQ9E2aWxQJ8fcx0EsfxqciA6kszkLrrjVBB8bPF0D_VkdR_dHLkgiwdoUsMKA6wwxy2s8EWFLaywgRXuwgo7WGEHK2xghQFWGD4fotO3_cnrge8O3_BFokNipOb1Ki8SlWYip4rSRImYJ7IAGV_xUvKcl5RIoWCLiBORqzJKRUh4EUlOeRTvo71qXslHCIu4TEFw5VRyRQlRuQpLmXEpQk5USmYeCuq3yISrTK8PSPnGjIaaEhYSNjj7yOKIUQav3UMvmgELW5Tl910Pt8jS9HcQ8NBBTSbmVvaSRWECUhtIsx561vwLbFf70ngl5-slS4si04nbHtq3tG0m1gpVnMHE_hatmX35zCjlUZrrCK_cONd0YQeSP_7Dgx6gW-16e4L2VpdreQjy8Kp8atD7C4kwr4I
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+for+a+difference+in+nitric+oxide+biosynthesis+between+healthy+women+and+men&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=FORTE%2C+P&rft.au=KNEALE%2C+B.+J&rft.au=MILNE%2C+E&rft.au=CHOWIENCZYK%2C+P.+J&rft.date=1998-10-01&rft.pub=Lippincott&rft.issn=0194-911X&rft.volume=32&rft.issue=4&rft.spage=730&rft.epage=734&rft_id=info:doi/10.1161%2F01.hyp.32.4.730&rft.externalDBID=n%2Fa&rft.externalDocID=2421241
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon